PFKFB3 and neoplasm: In fact, genetic ablation or pharmacologic inhibition of PFKFB3 can impair tip cell behavior and reduce sprouting, resulting in improved anti-cancer drug efficacy and decreased metastatic events in mouse tumor models (Cantelmo et al., 2016).